Bratton Capital Inc. 4
4 · Aquestive Therapeutics, Inc. · Filed Jul 26, 2018
Insider Transaction Report
Form 4
BRATTON DOUGLAS K
Director10% Owner
Transactions
- Purchase
Common Stock
2018-07-24$15.00/sh+165,000$2,475,000→ 165,000 total(indirect: See Footnotes)
Holdings
- 87,455(indirect: See Footnotes)
Common Stock
- 2,213,314(indirect: See Footnotes)
Common Stock
- 2,249,077(indirect: See Footnotes)
Common Stock
- 2,755,541(indirect: See Footnotes)
Common Stock
- 75,085
Common Stock
- 4,032,907(indirect: See Footnotes)
Common Stock
Footnotes (8)
- [F1]These securities are beneficially owned by MonoLine Partners, L.P. ("MonoLine").
- [F2]These securities are owned, as indicated, by MonoLine, MRX Partners, LLC ("MRX Partners"), MonoLine Rx, L.P. ("Monoline Rx"), MonoLine Rx II, L.P. ("Monoline II"), and MonoLine Rx III, L.P. ("Monoline III"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the "Monoline Entities". Bratton Capital Management, L.P. ("Bratton Capital Management") is the general partner of each of the Monoline Entities. Bratton Capital, Inc. ("Bratton") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director of Bratton and has voting and investment power over all shares held by the Monoline Entities.
- [F3]These securities are beneficially owned by MRX Partners.
- [F4]These securities are beneficially owned by Monoline Rx.
- [F5]These securities are beneficially owned by Monoline II.
- [F6]These securities are beneficially owned by Monoline III.
- [F7]These securities are beneficially owned by MonoSol Rx Genpar, L.P. ("Monosol"). Bratton is the general partner of Monosol. The Reporting Person, Douglas K. Bratton, is the sole director of Bratton and has voting and investment power over all shares held by Monosol.
- [F8]Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein.